Sean N. Tucker
2023
In 2023, Sean N. Tucker earned a total compensation of $1.1M as Chief Scientific Officer at Biota Pharmaceuticals, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $121,414 |
|---|---|
| Option Awards | $428,840 |
| Salary | $428,267 |
| Stock Awards | $147,542 |
| Other | $11,422 |
| Total | $1,137,485 |
Tucker received $428.8K in option awards, accounting for 38% of the total pay in 2023.
Tucker also received $121.4K in non-equity incentive plan, $428.3K in salary, $147.5K in stock awards and $11.4K in other compensation.
Rankings
In 2023, Sean N. Tucker's compensation ranked 976th out of 2,338 executives tracked by ExecPay. In other words, Tucker earned more than 58.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 976 out of 2,338 | 58th |
Division Manufacturing | 575 out of 1,259 | 54th |
Major group Chemicals And Allied Products | 391 out of 711 | 45th |
Industry group Drugs | 381 out of 682 | 44th |
Industry Biological Products, Except Diagnostic Substances | 115 out of 165 | 30th |
Source: SEC filing on April 29, 2024.
Tucker's colleagues
We found two more compensation records of executives who worked with Sean N. Tucker at Biota Pharmaceuticals in 2023.
News
Biota Pharmaceuticals CEO Andrei Floroiu's 2023 pay falls 48% to $1.9M
April 29, 2024
Biota Pharmaceuticals CEO Andrei Floroiu's 2022 pay jumps 49% to $3.6M
April 28, 2023
Biota Pharmaceuticals CEO Wouter Latour's 2020 pay jumps 280% to $2.8M
April 30, 2021
Biota Pharmaceuticals CEO Wouter Latour's 2019 pay slips 12% to $748K
April 24, 2020
Biota Pharmaceuticals CEO Joseph Patti's 2018 pay rises 12% to $1.2M
March 11, 2019